TRIB - trinitybiotech.com Company Long-Term Debts

Graphic logo of Trinity Biotech PLC (TRIB)

The price chart for Trinity Biotech plc (TRIB) illustrates the dynamics of the company developing diagnostic systems. The business is currently implementing eco-packaging and energy-saving laboratory equipment, while the individual long-term debt metric stands at 0.00. High certification and patent costs for Uni-Gold create a moat against competitors, while the sale of diabetes and HIV tests serves as a steady cash cow.

TRIB Trinity Biotech PLC: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for Trinity Biotech (TRIB)

- price and consensus price forecast:
Share Price Trinity Biotech PLC|TRIB - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Trinity Biotech|TRIB - Total Company Value
- book capitalization data:
Equity per Share Trinity Biotech|TRIB - Book Capitalization|Market Capitalization to Book Value Ratio trinitybiotech.com|TRIB - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Trinity Biotech plc|TRIB - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Trinity Biotech PLC|TRIB - Company Debts|Debts to Net Assets Trinity Biotech|TRIB - Company Long-Term Debts|Short-Term Debt Volume Trinity Biotech
General company analysis:TRIB (Trinity Biotech plc)
Mass-produced product of trinitybiotech.com

The investment attractiveness of Trinity Biotech plc depends on the balance between expansion into eco-friendly packaging and its debt load. This indicator captures total liabilities with a maturity of over one year, allowing for an assessment of the business's dependence on borrowed capital and default risks. An analysis of the organization's long-term loans and borrowings reveals the funding pace of energy-efficient developments, determining the sustainability of shareholder value.

Competing companies

Company Long-Term Indebtedness agilent.com A|Quest Diagnostics Incorporated - Company Long-Term Debts|ILMN: Company Long-Term Debts|Company Long-Term Debt Cologuard|Revvity Corp (RVTY) - Company Long-Term Indebtedness|BIO (Bio-Rad Laboratories) - Company Long-Term Debts|Company Long-Term Debts NNNN|Company Long-Term Debt Sotera Health (SHC)|Company Long-Term Debt Quidel Corporation QDEL|OPK: Company Long-Term Liabilities|CareDx - Long-Term Debt|Company Long-Term Debt MRVI (Maravai LifeSciences)|FLGT - Long-Term Debt Volume|Standard BioTools - Company Long-Term Debts|CTKB (Cytek Biosciences Inc) - Long-Term Debt Volume|OSUR: Company Long-Term Debt|Long-Term Debt Volume Exagen Diagnostics (XGN)|Company Long-Term Liabilities MDxHealth SA|Amount of Long-Term Liabilities LUCD (luciddx.com)|Company Long-Term Debt Prenetics|Company Long-Term Loans and Borrowings Insight Molecular Diagnostics, Inc. IMDX|Company Long-Term Debts PRPH (ProPhase)|AIMD: Long-Term Debt Volume|Company Long-Term Debt Co-Diagnostics, Inc.|heartsciences.com (HSCS) - Company Long-Term Indebtedness|BMRA: Company Long-Term Debts|Long-Term Debt Volume Cardio Diagnostics Holdings, Inc. (CDIO)|Company Long-Term Liabilities Virax Biolabs Group Ltd|Amount of Long-Term Liabilities Bluejay Diagnostics Corp BJDX|AWH: Company Long-Term Liabilities|AXDX - Long-Term Debt|Company Long-Term Liabilities CENTOGENE (CNTG)|ENZ - Company Long-Term Loans and Borrowings|fresh2.co (FRES) - Company Long-Term Debts|Genetic Technologies Limited (GENE) - Company Long-Term Debt|ME: Company Long-Term Debts|Long-Term Debt Volume PMD